Effect of L-arginine on lower oesophageal sphincter motility in man

European Journal of Gastroenterology and Hepatology

Volumn 12, Issue 4, 2000, Pages 419-424

  Straathof, Jan Willem A ^a   Adamse, Marieke ^a   Onkenhout, Willem ^a   Lamers, Cornelis B H W ^a   Masclee, Ad A M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Gastro oesophageal reflux; L arginine; Lower oseophageal sphincter pressure; Transient lower oesophageal sphincter relaxation

Indexed keywords

AMINO ACID; ARGININE; CHOLECYSTOKININ; CITRULLINE; GASTRIN; NITRIC OXIDE; SODIUM CHLORIDE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; ESOPHAGUS MOTILITY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LOWER ESOPHAGUS SPHINCTER; MALE; MEAL; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033998720     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200012040-00009     Document Type: Article

References (22)

1. 1 Sanders KM, Ward SM. Nitric oxide as a mediator of nonadrenergic noncholinergic neurotransmission. Am J Physiol 1992; 262:G379-G392.
2. 2 Stark ME, Szurszewski JH. Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 1992; 103:1928-1949.
3. 3 Richards WG, Sugarbaker DJ. Neuronal control of esophageal function. Chest Surg Clin North Am 1995; 5:157-171.
4. 4 Bult H, Boeckxstaens GE, Pelckmans PA, Jordaens FH, Van Maercke YM, Herman AG. Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature 1990; 345:346-347.
5. 5 De Man JG, Pelckmans PA, Boeckxstaens GE, Bult H, Oosterbosch L, Herman AG, et al. The rofe of nitric oxide in inhibitory non-adrenergic non-cholinergic neurotransmission in the canine lower oesophageal sphincter. Br J Pharmacol 1991; 103:1092-1096.
6. 6 Anand N, Paterson WG. Role of nitric oxide in esophageal peristalsis. Am J Physiol 1994; 266:G123-G131.
7. 7 Yamato S, Saha JK, Goyal RK. Role of nitric oxide in lower esophageal sphincter relaxation to swallowing. Life Sci 1992; 50:1263-1272.
8. 8 Preiksaitis HG, Tremblay L, Diamant NE. Nitric oxide mediates inhibitory nerve effects in human esophagus and lower esophageal sphincter. Dig Dis Sci 1994; 39:770-775.
9. 9 Tottrup A, Ny L, Alm P, Larsson B, Forman A, Andersson KE. The role of the L-arginine/nitric oxide pathway for relaxation of the human lower oesophageal sphincter. Acta Physiol Scand 1993; 149:451-459.
10. 10 Mittal RK, Holloway RH, Penagini R, Blackshaw LA, Dent J. Transient lower esophageal sphincter relaxation. Gastroenterology 1995; 109:601-610.
11. 11 Dodds WJ, Dent J, Hogan WJ, Helm JF, Hauser R, Patel GK, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1982; 307:1547-1552.
12. 12 Holloway RH, Kocyan P, Dent J. Provocation of transient lower esophageal sphincter relaxations by meals in patients with symptomatic gastroesophageal reflux. Dig Dis Sci 1991; 36:1034-1039.
13. 13 Boulant J, Fioramonti J, Dapoigny M, Bommelaer G, Bueno L. Cholecystokinin and nitric oxide in transient lower esophageal sphincter relaxation to gastric distension in dogs. Gastroenterology 1994; 107:1059-1066.
14. 14 Jansen JB, Lamers CBHW. Radioimmunoassay of cholecystokinin in human tissue and plasma. Clin Chim Acta 1983; 131:305-316.
15. 15 Jansen JB, Lamers CBHW. Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome. Gastroenterology 1982; 83:173-178.
16. 16 Pijl H, Koppeschaar HP, Cohen AF, Iestra JA, Schoemaker HC, Frolich M, et al. Evidence for brain serotonin-mediated control of carbohydrate consumption in normal weight and obese humans. Int J Obes Related Metab Dis 1993; 17:513-520.
17. 17 Smulders RA, Stehouwer CD, Olthof CG, Van Kamp GJ, Teerlink T, De Vries PM, Donker AJ. Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin Sci 1994; 87:37-43.
18. 18 Bode-Boger SM, Boger RH, Creutzig A, Tsikas D, Gutzki FM, Alexander K, Frolich JC. L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci 1994; 87:303-310.
19. 19 Willis S, Allescher HD, Stoschus B, Schusdziarra V, Classen M, Schumpelick V. Double blind placebo controlled study on the effect of the nitric oxide donor molsidomin and the 5-HT3 antagonist ondansetron on human esophageal motility. Z Gastroenterol 1994; 32:632-636.
20. 20 Luiking YC, Weusten BL, Portincasa P, Van Der Meer R, Smout, AJ, Akkermans LM. Effects of long-term oral L-arginine on esophageal motility and gallbladder dynamics in healthy humans. Am J Physiol 1998; 274:G984-G991.
21. 21 Ledeboer M, Masclee AAM, Batstra MR, Jansen JB, Lamers CBHW. Effect of cholecystokinin on lower oesophageal sphincter pressure and transient lower oesophageal sphincter relaxations in humans. Gut 1995; 36:39-44.
22. 22 Boulant J, Mathieu S, D'Amato M, Abergel A, Dapoigny M, Bommelaer G. Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans. Gut 1997; 40:575-581.